Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

PHASE2CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

March 9, 2023

Study Completion Date

August 31, 2023

Conditions
Severe Hypertriglyceridemia
Interventions
DRUG

ARO-APOC3

2 doses of ARO-APOC3 by subcutaneous (sc) injection

DRUG

Placebo

calculated volume to match active treatment by sc injection

Trial Locations (74)

1010

Research Site 73, Grafton

2025

Research Site 71, Papatoetoe

2050

Research Site 42, Camperdown

2921

Research Site 63, Komárom

3010

Research Site 72, Rotorua

3168

Research Site 47, Clayton

3200

Research Site 62, Gyöngyös

Research Site 70, Hamilton

4032

Research Site 61, Debrecen

4064

Research Site 44, Brisbane

4400

Research Site 65, Nyíregyháza

4405

Research Site 64, Nyíregyháza

4556

Research Site 45, Sippy Downs

5000

Research Site 46, Adelaide

5600

Research Site 60, Békéscsaba

6009

Research Site 43, Perth

6500

Research Site 57, Baja

Research Site 58, Baja

8011

Research Site 69, Christchurch

10029

Research Site 27, New York

11106

Research Site 25, Long Island City

12553

Research Site 26, New Windsor

20110

Research Site 41, Manassas

28557

Research Site 29, Morehead City

29607

Research Site 35, Greenville

30338

Research Site 16, Dunwoody

32127

Research Site 14, Port Orange

33144

Research Site 10, Miami

Research Site 9, Miami

33155

Research Site 11, Miami

33166

Research Site 12, Miami Springs

33173

Research Site 8, Miami

33308

Research Site 6, Fort Lauderdale

33434

Research Site 5, Boca Raton

37421

Research Site 36, Chattanooga

38801

Research Site 21, Tupelo

40503

Research Site 18, Lexington

43537

Research Site 33, Maumee

45005

Research Site 32, Franklin

45419

Research Site 31, Dayton

52074

Research Site 55, Aachen

55455

Research Site 20, Minneapolis

58104

Research Site 30, Fargo

59901

Research Site 22, Kalispell

60005

Research Site 17, Arlington Heights

68114

Research Site 23, Omaha

73135

Research Site 34, Oklahoma City

77030

Research Site 38, Houston

77099

Research Site 39, Houston

78249

Research Site 40, San Antonio

89121

Research Site 24, Las Vegas

90211

Research Site 2, Beverly Hills

92292

Research Site 4, Palm Springs

L4K 4M2

Research Site 49, Concord

N6A 5A5

Research Site 50, London

M4G 3E8

Research Site 51, Toronto

G7H5H6

Research Site 52, Chicoutimi

J4V2G8

Research Site 53, Greenfield

H2W2T2

Research Site 54, Montreal

0 4103

Research Site 56, Leipzig

H-8230

Research Site 59, Balatonföldvár

1105 AZ

Research Site 66, Amsterdam

3318 AT

Research Site 67, Dordrecht

08601

Research Site 68, Sneek

85-605

Research Site 74, Bydgoszcz

82-300

Research Site 75, Elblag

81-157

Research Site 76, Gdynia

94-048

Research Site 83, Lodz

32-600

Research Site 78, Oświęcim

61-655

Research Site 79, Poznan

24-100

Research Site 80, Puławy

35-055

Research Site 81, Rzeszów

05-200

Research Site 82, Wołomin

99-100

Research Site 77, Łęczyca

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY